New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, November 11, 2026

Back to the front page

DoorDash’s FBA Moment

DoorDash’s $17 billion Instacart deal targets DashMart warehouse scale, where 99%+ order accuracy and faster delivery address the limits of store-based grocery fulfillment.

DASH $79BKR $41B
MBI Deep Dives 1 click

From X

@aleabitoreddit

Serenity on X

This aged pretty well, when I said this last year in 2025, Clickhouse was a $6.7B company... Now as an update, their secondary valuation sits around ~$50B, which $NBIS owns 25%+ of. I've always liked Nebius the most because sum of parts, with all their lesser known subsidiaries growing alongside their core neocloud business. Including Avride (self-driving), Clickhouse, Toloka, and other subsidiaries that they owned. This year Nebius also acquired: - Tavily (web search and retrival) - Clarifai (Inference orchestration) Which scale independently as well (the others were integrated into Nebius Token Factory). Hard to view $NBIS as just another neocloud when it has billions in scaling value outside its core infrastructure business.
@KEDM_COM

KEDM.com on X

In June, Alphabet $GOOGL surprised the market by announcing the mother of all equity raises. The plan was to raise $80 billion, consisting of $15b in convertible preferred stock and $25b in common stock, followed by a $40b ATM set to start in Q3. The official reason was to fund AI Capex and pay taxes on employee stock compensation. The timing seemed obvious … they wanted to get ahead of a liquidity crunch as SpaceX $SPCX, OpenAI, and Anthropic lined up their IPOs. SpaceX went public in June, and Anthropic’s November IPO could raise up to $64.4b, with shares expected to start trading on Nasdaq as $ANT on November 19. We recently wrote about how the typical IPO underperforms by ~20% on a 3-year horizon. This effect was more pronounced when companies were unprofitable, resulting in an average underperformance of 30%. Companies like $SPCX are not set up for patient buy-and-hold investors. Index providers waived the profitability requirement and cut the seasoning window from 90 days to 5. Passive investors will be forced to buy shares just after the initial IPO pump, and just before the accelerated unlock. There’s a 200-year history of finance bros dumping on retail. SpaceX simply figured out how to do it at scale.
@StableBread

Fajasy on X

The FTC and eight states sued Toast $TOST, the restaurant software and payments company, on October 29, the day after its President and CFO Elena Gomez gave notice. The complaint alleges $TOST: → Enrolled restaurants in subscription add-ons they didn’t agree to. → Charged an undisclosed early termination fee of $150 for each month left on a contract. → Added a $0.99 fee to some online orders over $10 from September 2021 to July 2023, money that went to Toast rather than the restaurants. → Required 30 days’ written notice to cancel without clearly disclosing it, and treated a cancellation as a default on any Toast Capital loan, making the full balance due at once. → Advertised “24/7/365” support that customers say they couldn’t reach. The 10-Q says $TOST will “vigorously defend its interests” and can’t yet estimate a possible loss. CEO Aman Narang argued on the Q3 call that ROSCA (the Restore Online Shoppers’ Confidence Act, a federal law on online subscriptions) was never meant for negotiated business contracts: “If ROSCA were to apply to B2B custom-negotiated contracts in a B2B context, it would have huge implications for really the whole industry and business contracts in general.” He also said $TOST had been cooperating with the FTC “over the past year” before it sued, and that “how we settle the suit” won’t change Toast’s long-term path. With $1.89B of cash and marketable securities and no debt, $TOST can afford a fine, so the bigger risk to me is an injunction that could possibly change how it sells, prices, and cancels contracts.
@convequity

Convequity on X

If $SPCX makes its own chips at Terafab, our model has a gigawatt of orbital compute costing about $10 billion to build, down from about $33 billion with purchased GPUs. In orbit, the silicon decides the returns more than Starship does. This comes from our SPCX Special View valuation model. It estimates how fast capacity comes online, limited by equipment supply and launches. The first gigawatt reaches orbit in 2027. Our Base case buys GPUs. Chips and racks are about 80% of the cost, launch about 11%. Each gigawatt earns $40 billion a year renting out compute through 2028, falling to $20 billion from 2031 as GPU-hour prices fall. Terafab is Musk's planned chip factory. In our Full Terafab case, chips and racks cost one-eighth as much, about a third of the total, and launch becomes the largest item at 37%. A customer like Anthropic would want its own chips rather than rent SPCX's. Terafab chips would most likely run SPCX's own AI models, sold through an API. We assume that earns 50% more. Over a seven-year satellite life, a gigawatt's net present value is about $88 billion with purchased GPUs, $111 billion renting out Terafab compute, and $172 billion running SPCX's own models. The fleet reaches 140 gigawatts in 2036. Multiplying 140 by $172 billion values SPCX at about $24 trillion. This counts the cost of building and launching the hardware, but not of developing SPCX's own models.

Investor Letters

All letters

Cat-Scratch Fervo

Fervo Energy raised $2 billion in its May IPO, then fell nearly 70% below issue price after a Morpheus short report, despite targeting 1 GW…

FRVO $2.3B
Doomberg 4 clicks

Sea Ltd Earnings Update: Q3 2026

Sea Ltd reported Q3 2026 revenue of $8.6 billion, up 43.4% year over year, while net income rose 34.0%.

SE $48B
SixSigmaCapital: Navigating the Financial Markets 4 clicks
EFXT · long

Enerflex LTD

Enerflex, a $3 billion natural gas infrastructure and equipment company, blends contracted energy-services cash flows with equipment…

EFXT $2.5B
Value Investors Club 4 clicks

GLP-1 winners and losers

GLP-1 drugs are gaining traction across Asia as Chinese developers advance candidates and Indian generics slash prices, reshaping prospects…

NVO $179B
Asian Century Stocks 3 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 82 of 283

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

369 firms

Sectors

Ordered by how often our editor reaches for them.